Ara
Toplam kayıt 14, listelenen: 11-14
Utilization of injectable drugs for communicable and non-communicable diseases in primary healthcare: A retrospective study in Turkey
(AVES, 2023)
Objective: Primary care, which is often the first level of contact for patients with various communicable diseases (CDs) and noncommunicable diseases (NCDs), might exhibit patterns of injectable drug utilization different ...
The impact of chiral switch on drug labeling in Turkey: Indication, posology, and adverse effects
(Marmara University, 2023)
Objective: Chiral switch, which involves replacing racemic drugs to market them as pure enantiomers, is presumed to improve efficacy and safety. Data on how chiral switch-related changes are represented in summary of product ...
Drug utilization studies in Turkiye: A systematic review
(Kare Publishing, 2024)
OBJECTIVE: Drug utilization studies (DUS) provide a framework for drug utilization at the national or targeted population level and important information on unmet medical needs, particularly in assessing the rationality ...
Use of lipid-lowering drugs in restricted health access settings: Results from the trends in drug utilization during covıd-19 pandemic in Turkey (PANDUTI-TR) study
(2024)
Background: COVID-19 restrictions prompted changes in chronic disease management and lifestyle modifications, potentially altering cardiometabolic indicators and lipid-lowering pharmacotherapy patterns. We aimed to assess ...